it provides companies with the capital they need to fund their growth, in three key areas: venture capital, growth & buyout capital and infrastructure.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Bioparc 1 - 850 Boulevard Sébastien Brant
Strasbourg, 67400
France

Phone

+33 3 90 40 61 52

Website

www.domaintherapeutics.com

Email Address

[email protected]

Overview

We are committed to improve patients' life and to support physicians by delivering innovative immunotherapies to fight cancer. We aim at making an impactful difference for patients suffering from cancer by discovering first-in-class and best-in-class treatments to tackle GPCR-mediated immunosuppression. Leveraging our expertise, innovative approach and proprietary platform, we develop a unique pipeline in immune-oncology and progress our most advanced programs towards the clinic.

Profile

Social Media

Domain Therapeutics Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Pascal Neuville

Chief Financial Officer

Stanislas Malmezat

Chief Scientific Officer

Xavier Leroy

VP - Bus. Development

Marjorie Sidhoum

VP - Human Resources

Aurélie Maisner

Browse more venture capital transactions:

Prev: 5/10/2022: Moma Therapeutics venture capital transaction
Next: 5/10/2022: Co-Create venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary